| # | Drug | Count |
|---|---|---|
| 0 | FLUDARABINE PHOSPHATE | 20 |
| 1 | METHOTREXATE SODIUM | 13 |
| 2 | METHOTREXATE | 12 |
| 3 | CYTARABINE | 11 |
| 4 | CYCLOPHOSPHAMIDE | 10 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 10 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 10 |
| 7 | TREOSULFAN | 10 |
| 8 | AZACITIDINE | 9 |
| 9 | AZACITIDINE FOR | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TREOSULFAN | 10 | 0.0036 |
| 1 | PURIXAN | 1 | 0.0013 |
| 2 | DEXRAZOXANE FOR INJECTION | 1 | 0.0011 |
| 3 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 4 | DEFIBROTIDE SODIUM | 2 | 0.0006 |
| 5 | FLUDARABINE PHOSPHATE | 20 | 0.0005 |
| 6 | THIOGUANINE | 1 | 0.0005 |
| 7 | MERCAPTOPURINE | 6 | 0.0003 |
| 8 | BUSULFAN | 5 | 0.0003 |
| 9 | AZACITIDINE | 9 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 1 | Bile Acid [EPC] | 2 | 0.0001 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 14 | 0.0001 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 5 | Alkylating Drug [EPC] | 11 | 0.0000 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Azole Antifungal [EPC] | 6 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 12 | 0.0000 |